4.8 Article

A Checkpoint-Regulatable Immune Niche Created by Injectable Hydrogel for Tumor Therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1

Zi Yin et al.

Summary: Exosomes, specifically those derived from cancer cells, contain immunosuppressive proteins such as PD-L1, which can hinder immune responses and promote tumor progression. Blocking the interaction between PD-1 and PD-L1 can enhance the efficacy of cancer treatment by restoring anti-tumor immunity.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Chemistry, Multidisciplinary

Modulating the Bioactivity of Mucin Hydrogels with Crosslinking Architecture

Kun Jiang et al.

Summary: The crosslinking architecture of hydrogels affects their bioactivity, with different crosslinking strategies influencing properties such as enzymatic degradation sensitivity and cell response. Modulating the accessibility of binding sites through the choice of crosslinking strategy can alter substrate accessibility to proteases and the pattern of exposed sialic acid residues to macrophages.

ADVANCED FUNCTIONAL MATERIALS (2021)

Review Oncology

Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy

Samantha M. Morrissey et al.

TRENDS IN CANCER (2020)

Article Biochemistry & Molecular Biology

Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory

Mauro Poggio et al.

Article Chemistry, Multidisciplinary

Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade

Shuangjiang Yu et al.

ADVANCED MATERIALS (2018)

Article Cell Biology

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Angel Garcia-Diaz et al.

CELL REPORTS (2017)

Review Biochemistry & Molecular Biology

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Padmanee Sharma et al.

Article Biochemistry & Molecular Biology

Stimulating the Release of Exosomes Increases the Intercellular Transfer of Prions

Belinda B. Guo et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Medicine, General & Internal

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

Martin Reck et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Multidisciplinary Sciences

Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity

R. Dixon Dorand et al.

SCIENCE (2016)

Review Medicine, Research & Experimental

Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future

Lieping Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Review Multidisciplinary Sciences

The future of immune checkpoint therapy

Padmanee Sharma et al.

SCIENCE (2015)

Review Medicine, Research & Experimental

Immune Modulation in Cancer with Antibodies

David B. Page et al.

ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)

Article Cell Biology

Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells

Stefani Spranger et al.

SCIENCE TRANSLATIONAL MEDICINE (2013)

Article Engineering, Biomedical

Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds

B Balakrishnan et al.

BIOMATERIALS (2005)

Article Biochemistry & Molecular Biology

Exosome release is regulated by a calcium-dependent mechanism in K562 cells

A Savina et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Biochemistry & Molecular Biology

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

HD Dong et al.

NATURE MEDICINE (2002)

Article Biotechnology & Applied Microbiology

Degradation of partially oxidized alginate and its potential application for tissue engineering

KH Bouhadir et al.

BIOTECHNOLOGY PROGRESS (2001)